Clinical Trials Directory

Trials / Completed

CompletedNCT06146322

Barley Beta-glucan, Glycemic Control, and Appetite

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Washington State University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Novel barley varieties high in the soluble fiber β-glucan have the capacity to improve population health through improving glycemic control. Sweetened and unsweetened wholegrain barley foods were tested in a randomized, controlled, crossover human clinical trial to assess impact on postprandial appetite and food intake.

Conditions

Interventions

TypeNameDescription
OTHERWRUnsweetened preload condition: 240 mL white glutinous rice, 250 kcal, 0 g β-glucan
OTHERLBUnsweetened preload condition: 240 mL low β-glucan barley, 250 kcal, \~4 g β-glucan
OTHERMBUnsweetened preload condition: 240 mL medium β-glucan barley, 250 kcal, \~5 g β-glucan
OTHERHBUnsweetened preload condition: 240 mL high β-glucan barley, 250 kcal, \~6 g β-glucan
OTHERWR+50g HFCSSweetened condition with high fructose corn syrup (HFCS): 240 mL white glutinous rice + 50g HFCS, 391 kcal, 0 g β-glucan
OTHERLB + 50 g HFCSSweetened condition with high fructose corn syrup (HFCS): 240 mL low β-glucan barley + 50 g HFCS, 391 kcal, \~4 g β-glucan
OTHERMB + 50 g HFCSSweetened condition with high fructose corn syrup (HFCS): 240 mL medium β-glucan barley + 50 g HFCS, 391 kcal, \~5 g β-glucan
OTHERHB + 50 g HFCSSweetened condition with high fructose corn syrup (HFCS): 240 mL high β-glucan barley + 50 g HFCS, 391 kcal, \~6 g β-glucan

Timeline

Start date
2019-10-01
Primary completion
2020-10-31
Completion
2020-10-31
First posted
2023-11-24
Last updated
2023-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06146322. Inclusion in this directory is not an endorsement.